Conversely, IRE1 overexpression in colon cancer cells resulted in reduced tumour progression and increased tumour‐infiltrating lymphocytes, thus providing an anti‐tumour role of IRE1, which triggers the immune response based on metabolic cues. This evidence concerns the gene ERN1 and malignant colon neoplasm.